Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

NCT00293930 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00293930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00293930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
Not reported
Completion date
November 30, 2006
Enrollment
645 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis